A non-selective COX inhibitor (IC50s = 0.9-2.7 and 1.5-20 μM, for human COX-1 and COX-2, respectively); reduces inflammation and pain associated with osteoarthritis, rheumatoid arthritis, gout, and ankylosing spondylitis; has increased ex vivo skin permeability over diclofenac (sodium salt),